Megadose therapy for vitamin D deficiency

Medical Journal of Australia

Volumn 183, Issue 1, 2005, Pages 4-5

  Ebeling, Peter R ^a,b  

^a Department of Diabetes and Endocrinology ^*  (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; COLECALCIFEROL; ERGOCALCIFEROL; PLACEBO; VITAMIN D;

AUSTRALIA; CLINICAL TRIAL; DISEASE CLASSIFICATION; DRUG MEGADOSE; EDITORIAL; FRAGILITY FRACTURE; HEALTH HAZARD; HEALTH SURVEY; HUMAN; HYPOCALCEMIA; MALABSORPTION; MYALGIA; MYOPATHY; NURSING HOME; OSTEOMALACIA; OSTEOPOROSIS; PATIENT COMPLIANCE; PIGMENT DISORDER; PREVALENCE; RICKETS; RISK ASSESSMENT; SECONDARY HYPERPARATHYROIDISM; TREATMENT OUTCOME; VITAMIN D DEFICIENCY;

EID: 21844462831     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2005.tb06875.x     Document Type: Editorial

References (14)

1. Chatfield S, Ebeling PR. Osteoporosis prevention and treatment: the importance of vitamin D. Mod Med 2005; 6: 16-32.
2. Working Group of the Australian and New Zealand Bone and Mineral Society, Endocrine Society of Australia and Osteoporosis Australia. Vitamin D and adult bone health in Australia and New Zealand: a position statement. Med J Aust 2005; 182: 281-285.
3. Pasco JA, Henry MJ, Nicholson GC, et al. Vitamin D status of women in the Geelong Osteoporosis Study: association with diet and casual exposure to sunlight. Med J Aust 2001; 175: 401-405.
4. McGrath JJ, Kimlin MG, Saha S, et al. Vitamin D insufficiency in southeast Queensland. Med J Aust 2001; 174: 150-151.
5. Frame B, Parfitt AM. Osteomalacia: current concepts. Ann Intern Med 1978; 89: 966-982.
6. Holick MF, Siris ES, Binkley N, et al. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005; 90: 3215-3224. Epub 2005 Mar 29.
7. Peter R, Mishra V, Fraser WD. Severe hypocalcaemia after being given intravenous bisphosphonate. BMJ 2004; 328: 335-336.
8. Maclsaac RJ, Seeman E, Jerums G. Seizures after alendronate. J R Soc Med 2002; 95: 615-616.
9. Diamond TH, Ho KWK, Rohl PG, Meerkin M. Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety. Med J Aust 2005; 183: 10-12.
10. Anderson FH, Smith HE, Raphael HM, et al. Effect of annual intramuscular vitamin D supplementation on fracture risk in 9440 community living older people: the Wessex Fracture Prevention Trial [abstract]. J Bone Miner Res 2004; 19(Suppl 1): Abstract no. 1220.
11. 3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992; 327: 1637-1642.
12. Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age and older. N Engl J Med 1997; 337: 670-676.
13. 3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: a randomised double blind controlled trial. BMJ 2003; 326: 469-475.
14. 3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 2005; 365: 1621-1628.